TSE:PRN Profound Medical (PRN) Price, Holdings, & News C$8.09 -0.16 (-1.94%) As of 09/23/2026 03:59 PM Eastern Add Share Share Stock Analysis Stock AnalysisChartFDA EventsHoldingsNews and TrendsRatings About Profound Medical (TSE:PRN) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Profound Medical alerts:Sign Up Key Stats Today's RangeC$7.98▼C$8.1550-Day RangeC$7.92▼C$11.7652-Week RangeC$6.52▼C$12.40Volume15,313 shsAverage Volume15,771 shsMarket CapitalizationC$295.61 millionAssets Under ManagementC$131.70 millionDividend Yield7.05%Net Expense Ratio0.60%Aggregate RatingModerate Buy ETF Overview Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum. The company also offers Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. Profound Medical Corp. is headquartered in Mississauga, Canada. Read More Profound Medical ExpensesTypePRNIndustrials ETFsEquity ETFsTSE ETFsAll ETFsManagement Fee0.50%0.50%0.57%0.65%0.53%Other Expenses0.14%2.11%0.53%0.14%0.54%Total Expense0.64%1.45%0.75%0.72%0.73%Fee Waiver-0.04%-3.86%-0.67%-0.04%-0.68%Net Expense0.60%0.56%0.63%0.70%0.60% Receive PRN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Profound Medical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PRN ETF News HeadlinesInsider Buying: Profound Medical (TSE:PRN) Insider Acquires 10,000 Shares of StockSeptember 18, 2026 | insidertrades.comProfound Medical to Present at BIG10 Growth ConferenceSeptember 4, 2026 | tipranks.comMILLIONAIRE MASTERCLASS INVITE: AltucherJames Altucher says Elon Musk is preparing an unprecedented project set to surface on September 25. Altucher is hosting a free masterclass revealing what he says is locked inside a sealed briefcase detailing Musk's plans. Attendees who join early can also access a $1,000 bonus offer included with the presentation.September 24 at 1:00 AM | Paradigm Press (Ad)Profound Medical Names Richard Fabian as New PresidentSeptember 3, 2026 | tipranks.comProfound Medical Corp.August 21, 2026 | barrons.comProfound Medical Launches Enhanced TULSA-PRO Software UpgradeAugust 17, 2026 | tipranks.comSee More Headlines PRN ETF - Frequently Asked Questions How have PRN shares performed this year? Profound Medical's stock was trading at C$10.77 at the start of the year. Since then, PRN stock has decreased by 24.9% and is now trading at C$8.09. How were Profound Medical's earnings last quarter? Profound Medical Corp. (TSE:PRN) released its earnings results on Thursday, August, 6th. The company reported ($0.37) earnings per share for the quarter. The company earned $3.53 million during the quarter. Profound Medical had a negative net margin of 170.92% and a negative trailing twelve-month return on equity of 62.45%. How do I buy shares of Profound Medical? Shares of PRN stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of Profound Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Profound Medical investors own include 10094 (IRD.TO) (IRD), Profound Medical (PROF), Whitecap Resources (WCP), Air Canada (AC), AXT (AXTI), Bank of Nova Scotia (BNS) and Enbridge (ENB). Fund Details IssuerInvesco Fund NameInvesco DWA Industrials Momentum ETF Tax ClassificationRegulated Investment Company Stock ExchangeTSECurrent SymbolTSE:PRN Inception Date10/12/2006 Fund ManagerPeter Hubbard, Michael Jeanette, Tony Seisser, Jonathan Nixon Webwww.profoundmedical.com Phone647-476-1350Fund Focus Asset ClassEquity BenchmarkDWA Industrials Technical Leaders Index CategorySector FocusIndustrials Development LevelDeveloped Markets RegionNorth America Number of Holdings45 Fund Statistics Assets Under Management$131.70 million Average Daily Volume$18.99 thousand Discount/Premium-0.74% Administrator, Advisor and Custodian AdministratorThe Bank of New York Mellon Corporation AdvisorInvesco Capital Management LLC CustodianThe Bank of New York Mellon Corporation DistributorInvesco Distributors, Inc. Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerSusquehanna Miscellaneous Outstanding Shares36,540,000Beta1.06 Creation Unit50,000 Creation Fee$500.00 The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report Top 10 PRN HoldingsComfort Systems USA (NYSE:FIX)Holding Weight: 5.02%Quanta Services (NYSE:PWR)Holding Weight: 4.67%Howmet Aerospace (NYSE:HWM)Holding Weight: 4.15%EMCOR Group (NYSE:EME)Holding Weight: 3.88%Jabil (NYSE:JBL)Holding Weight: 3.85%Caterpillar (NYSE:CAT)Holding Weight: 3.31%Sterling Infrastructure (NASDAQ:STRL)Holding Weight: 3.23%Clean Harbors (NYSE:CLH)Holding Weight: 3.01%TTM Technologies (NASDAQ:TTMI)Holding Weight: 2.87%Sanmina (NASDAQ:SANM)Holding Weight: 2.84%Full Holdings DetailsPRN Sector ExposurePRN Industry Exposure This page (TSE:PRN) was last updated on 9/24/2026 by MarketBeat.com Staff. From Our PartnersEveryone remembers January's silver spike. Then what?Silver is up more than 50 percent over the past year, yet interest has faded since its January record. The ...i2i Marketing Group, LLC | SponsoredA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredWhile SpaceX Gets the Spotlight, FJET Is Building What Comes Next!Starfighters Space (NYSE: FJET) operates the world's only commercial fleet of flight-ready Mach 2+ F-104 Starf...Trading Wire | SponsoredHow to get a stake in Anthropic — before the IPOAnthropic, the maker of Claude AI, has reportedly filed for an IPO that could arrive as early as October. Its ...Weiss Ratings | SponsoredThey're shrinking your dollars every single monthSince 2020, the dollar has lost roughly a quarter of its buying power. A $500,000 nest egg today buys about wh...American Alternative | SponsoredWhy I believe the AI market will split in Q4Matt McCall, who recommended Nvidia near $6 a share, says the AI market is splitting in two - just like the do...The Oxford Club | SponsoredArizona Gold Explorer Nears First-Ever Resource EstimateA little-known Arizona gold explorer just hit 66.2 metres grading 6.57 g/t gold, including 20.7 metres at 18.2...Wall Street Logic | SponsoredCongress Passes Landmark Digital Asset Law Wall Street Is WatchingThe House passed the Digital Asset Market Clarity Act 294 to 134, creating the most comprehensive financial te...Awesomely | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Profound Medical Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Profound Medical With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
